Breakthroughs in the fight against cancer are happening, and Cancer Tutor’s team of expert journalists cover all the angles. We report on medical legislation, cancer risk factors, symptoms, treatments, and more from prestigious journals and medical universities around the world.

Researchers discover path to brain cancer treatment

Glioblastoma multiforme (GMB) — the most common malignant primary brain tumor — is known for its ability to relapse. Researchers at the University of Texas M. D. Anderson Cancer Center have identified a pathway by…

Occupational styrene exposure may cause cancer

The Department of Occupational Medicine at Aarhus University in Denmark has concluded that styrene may cause cancer in humans. Styrene is a colorless liquid that evaporates easily. In its pure form, styrene has a sweet…

Study: Cancer deaths remain steady

A Cancer Statistics, 2017 report published in CA: A Cancer Journal for Clinicians states the death rate from all cancers combined in the United States has dropped by 25 percent during the past 25 years. “Cancer death rates peaked…

Canada is set to legalize marijuana by July 1, 2018

Canada is set to legalize marijuana by July 1, 2018, according to news reports, citing the week of April 10 for legislation to be introduced to Parliament. According to the CBC report, the country’s marijuana…

Grail to raise $1B on blood test to detect cancer

Grail is looking to expand its clinical validation of blood test for early-stage cancer detection through a venture capital investment of $1 billion. In a news release, the company said it will use the proceeds…

Cancer researchers: Cells respond to drug combination

A team of cancer researchers at the Biozentrum of the University of Basel in Switzerland has published in Science Advances that specific cancer cells respond to a combination of a diabetes medication and an antihypertensive drug. At…

Adoptive T cell ‘clones’ advancing immunotherapy

As immunotherapy gains traction in the fight against cancer, researchers continue to probe the benefits of adoptive T cells. In 2015, a team of scientists from Johns Hopkins School of Medicine infused specific cytotoxic T cells…

SPNS2 identified as possible key to metastasis

Sphingolipid Transporter 2 (SPNS2) is a protein-coding gene. A team of researchers at Sanger Institute in Cambridge report that it also led to a three-quarters reduction in tumors spreading to the lungs. [1] “We’ve learned…

Load More